Cathay Innovative Medical Hybrid Initiation Securities Investment Fund (abbreviation: Cathay Innovative Medical Hybrid Initiation C, code 018160) announced its latest net value on September 20, down 0.33%.
Founded on April 18, 2023, Cathay Innovative Healthcare Hybrid Sponsor C is based on the yield of the CSI Healthcare Index ×65% + the yield of the Hang Seng Healthcare Index (adjusted for valuation and exchange rate) ×15% + the yield of the China Bond Composite Index ×20%. The fund has returned -31.32% since its inception, -32.37% this year, -1.58% over the past month, and -27.47% over the past year. In the past year, the fund ranked 6941/7554 in its peer group.
The fund manager is Qiu Xiaoxu. Qiu Xiaoxu has managed (or intends to manage) the fund since March 29, 2023, with a return of -31.32% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 02192 | Yimaitong | 6.30% | 136055 | 926,300 |
| 688253 | Innova | 4.35% | 16780 | 639,500 |
| 01801 | Innovent | 4.31% | 18839 | 6327002273 |
| Gushengtang | 3.89% | 16698 | 571,500 | |
| 300049 | Furui shares | 3.49% | 10200 | 513,500 |
| 688139 | Haier Biotechnology | 3.48% | 13742 | 511,200 |
| 688301 | Yirui Technology | 3.37% | 4291 | 494,500 |
| 002044 | Meinian Health | 2.99% | 116400 | 440,000 |
| 688321 | Chipscreen Biotech | 2.99% | 25000 | 440,000 |
| 300633 | open medical | 2.99% | 11100 | 439,300 |
Ticker Name
Percentage Change
Inclusion Date
